MispaCount X Plus

MispaCount X Plus

MispaCount X Plus

Technical Specifications

Feature Specification
Analysis Type Fully Automated, 3-Part Differential
Throughput Up to 60 samples per hour
Principles Enhanced Electrical Impedance (Counting); Cyanide-free Colorimetry (HGB)
Parameters 21 reportable parameters + 2 Research parameters (NLR & PLR)
Histograms 3 (WBC, RBC, PLT)
Sample Volume 9 $\mu$L (Whole Blood); 20 $\mu$L (Pre-diluted/Capillary)
Data Storage Up to 200,000 results (including numeric and graphical data)
Display 10.4-inch TFT Color Touch Screen
Reagents 2-reagent system (Diluent & Lyse) + Probe Cleaner
Aperture Size 80 $\mu$m (WBC); 50 $\mu$m (RBC/PLT)
Connectivity LAN port (HL7), 4 USB ports, supports bi-directional LIS

 

Description

The Mispa Count X Plus is engineered for laboratories that prioritize precision and efficiency. Its most significant advancement is the inclusion of NLR (Neutrophil-to-Lymphocyte Ratio) and PLR (Platelet-to-Lymphocyte Ratio), which serve as valuable inflammatory markers for clinical prognosis.

The machine utilizes a dual-chamber system and high-tech Ruby apertures to ensure interference-free, quality results. Its micro-sampling requirement of just 9 $\mu$L makes it an industry leader for pediatric and neonatal applications, where drawing large blood volumes is a challenge

Key Features

  • Research Parameters: Includes NLR and PLR as standard, providing deeper diagnostic insights into a patient’s inflammatory response.
  • Micro-Sampling: Requires only 9 $\mu$L of whole blood, the ideal volume for pediatric and geriatric patients.
  • 2-Reagent Operation: Minimizes inventory costs and simplifies lab management by using only two routine reagents.
  • Massive Memory: Stores up to 200,000 patient results, allowing for extensive historical data tracking and QC management.
  • Smart Maintenance: Features automatic clog clearing and a user-friendly interface that guides technicians through routine cleaning cycles.

High-Resolution Interface: The 10.4-inch touchscreen

Send Inquiry